Implementation and evaluation of a stochastic control strategy for individualizing teicoplanin dosage regimen

Journal of Pharmacokinetics and Biopharmaceutics

Volumn 25, Issue 6, 1997, Pages 695-712

  Tod, Michel ^a,b   Alet, Patrice ^a   Lortholary, Olivier ^a,b   Petitjean, Olivier ^a,b  

^a AVICENNE HOSPITAL   (France)

^b UNIVERSITÉ PARIS 13   (France)

Author keywords

Stochastic control; Teicoplanin; Therapeutic drug monitoring

Indexed keywords

TEICOPLANIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BAYES THEOREM; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DOSE RESPONSE; DRUG DISPOSITION; DRUG DOSE; DRUG MONITORING; MAINTENANCE THERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOCHASTIC MODEL;

AGE FACTORS; ANTI-BACTERIAL AGENTS; BAYES THEOREM; BODY WEIGHT; EVALUATION STUDIES; HUMANS; RETROSPECTIVE STUDIES; SEX FACTORS; STOCHASTIC PROCESSES; TEICOPLANIN;

EID: 0031397489     PISSN: 0090466X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025729817252     Document Type: Article

References (20)

1. A. P. R. Wilson, R. N. Grüneberg, and H. Neu. A critical review of the dosage of teicoplanin in Europe and the USA. Int. J. Antimicrob. Agents 4 (Suppl. 1):S1-S30 (1994).
2. F. Menichetti, P. Martino, G. Bucaneve, et al. Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile neutropenic patients with hematologic malignancies. Antimicrob. Agents Chemother. 38:2041-2046 (1994).
3. O. Lortholary, M. Tod, N. Rizzo, C. Padoin, O. Biard, P. Casassus, L. Guillevin, and O. Petitjean. Population pharmacokinetic study of teicoplanin in severely neutropenic patients. Antimicrob. Agents Chemother. 40:1242-1247 (1996).
4. D. Greenwood, K. Bigdood, and M. Turner. A comparison of the responses of staphylococci and streptococci to teicoplanin and vancomycin. J. Antimicrob. Agents 20:155-164 (1987).
5. B. Vogelman, S. Gudmunsson, J. Legett, J. Turnidge, S. Ebert, and W. A. Craig. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J. Infect. Dis. 158:831-847 (1988).
6. H. F. Chambers and S. Kennedy. Effects of dosage, peak and trough concentrations in serum, protein binding and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis. Antimicrob. Agents Chemother. 34:510-514 (1990).
7. A. E. Zimmerman, B. G. Katona, and K. I. Plaisance. Association of vancomycin serum concentrations with outcomes in patients with Gram-positive bacteremia. Pharmacotherapy 15:85-91 (1995).
8. P. L. Carver, C. H. Nightingale, R. Quintiliani, K. Sweeney, R. C. Stevens, and E. Madezo. Pharmacokinetics of single- and multiple-dose teicoplanin in healthy volunteers. Antimicrob. Agents Chemother. 33:82-86 (1989).
9. J. A. Smithers, H. K. Kulmala, G. A. Thompson, K. K. Anthony, E. W. Lewis, S. J. Ruberg, M. T. Kenny, J. K. Dulworth, and M. A. Brackman. Pharmacokinetics of teicoplanin upon multiple-dose intravenous administration to healthy volunteers. Antimicrob. Agents Chemother. 36:115-120 (1992).
10. K. Katz and D. Z. D'Argenio. Implementation and evaluation of control strategies for individualizing dosage regimens, with application to the aminoglycosides antibiotics. J. Pharmacokin. Biopharm. 14:523-537 (1986).
11. N. Taright, F. Mentré, A. Mallet, and R. Jouvent. Nonparametric estimation of population characteristics of the kinetics of lithium from observational and experimental data: Individualization of chronic dosing regimen using a new Bayesian approach. Ther. Drug Monit. 16:258-269 (1994).
12. J. C. Wakefield. An expected loss approach to the design of dosage regimens via sampling based methods. Statistician 43:13-29 (1994).
13. J. C. Wakefield. Bayesian individualisation via sampling-based methods. J. Pharmacokin. Biopharm. 24:103-131 (1996).
14. J. G. Wagner. Pharmacokinetics for the Pharmaceutical Scientist, Technomic, Lancaster, PA, 1993.
15. D. W. Cockroft and M. H. Gault. Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41 (1976).
16. F. Mentré, A. Mallet and D. Baccart. Optimal design in random effects models. Biometrika 84:429-442 (1997).
17. W. H. Press, S. A. Teukolsky, W. T. Vetterling, and B. P. Flannery. Numerical Recipes in C: The Art of Scientific Computing, Cambridge University Press, Cambridge, U.K., 1992.
18. L. B. Sheiner and S. Beal. Some suggestions for measuring predictive performances. J. Pharmacokin. Biopharm. 9:503-513 (1981).
19. Y. Tanigawara, I. Yano, K. Kawakatsu, K. Nishimura, M. Yasuhara, and R. Hori. Predictive performance of the Bayesian analysis: Effect of blood sampling time, population parameters and pharmacostatistical model. J. Pharmacokin. Biopharm. 22:59-71 (1994).
20. S. Vozeh and C. Steiner. Estimates of the population pharmacokinetic parameters and performance of Bayesian feed back: A sensitivity analysis. J. Pharmacokin. Biopharm. 15:511-528 (1987).